Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX - New York Stock Exchange, Inc. - US4576511079 - Common Stock - Currency: USD

15.29  -0.48 (-3.04%)

After market: 15.4 +0.11 (+0.72%)

Fundamental Rating

6

Taking everything into account, INVX scores 6 out of 10 in our fundamental rating. INVX was compared to 62 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is growing strongly while it is still valued neutral. This is a good combination! These ratings could make INVX a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

INVX had negative earnings in the past year.
In the past year INVX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.05%, INVX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
INVX has a better Return On Equity (12.56%) than 67.74% of its industry peers.
The Return On Invested Capital of INVX (6.88%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 10.05%
ROE 12.56%
ROIC 6.88%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

INVX has a Profit Margin of 15.61%. This is amongst the best in the industry. INVX outperforms 91.94% of its industry peers.
INVX's Profit Margin has improved in the last couple of years.
INVX's Operating Margin of 11.68% is fine compared to the rest of the industry. INVX outperforms 61.29% of its industry peers.
In the last couple of years the Operating Margin of INVX has grown nicely.
The Gross Margin of INVX (34.30%) is better than 69.35% of its industry peers.
INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.68%
PM (TTM) 15.61%
GM 34.3%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for INVX has been increased compared to 1 year ago.
INVX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 4.28 indicates that INVX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.28, INVX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
The Debt to FCF ratio of INVX is 0.44, which is an excellent value as it means it would take INVX, only 0.44 years of fcf income to pay off all of its debts.
INVX's Debt to FCF ratio of 0.44 is amongst the best of the industry. INVX outperforms 91.94% of its industry peers.
INVX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, INVX belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.44
Altman-Z 4.28
ROIC/WACC0.75
WACC9.15%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

INVX has a Current Ratio of 3.94. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.94, INVX belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
INVX has a Quick Ratio of 2.28. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INVX (2.28) is better than 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 2.28
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

The earnings per share for INVX have decreased strongly by -126.67% in the last year.
INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
The Revenue has grown by 81.84% in the past year. This is a very strong growth!
INVX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.76% yearly.
EPS 1Y (TTM)-126.67%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%775%
Revenue 1Y (TTM)81.84%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%98.42%

3.2 Future

INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 158.86% yearly.
The Revenue is expected to grow by 47.17% on average over the next years. This is a very strong growth
EPS Next Y525.4%
EPS Next 2Y158.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year111.46%
Revenue Next 2Y47.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INVX. In the last year negative earnings were reported.
INVX is valuated reasonably with a Price/Forward Earnings ratio of 10.57.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INVX is on the same level as its industry peers.
INVX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.74.
Industry RankSector Rank
PE N/A
Fwd PE 10.57
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

INVX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. INVX is more expensive than 79.03% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INVX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 13.28
EV/EBITDA 8.43
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INVX may justify a higher PE ratio.
INVX's earnings are expected to grow with 158.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y158.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVEX INTERNATIONAL INC

NYSE:INVX (5/5/2025, 8:19:01 PM)

After market: 15.4 +0.11 (+0.72%)

15.29

-0.48 (-3.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners47.97%
Inst Owner Change0.83%
Ins Owners1.52%
Ins Owner Change2.9%
Market Cap1.06B
Analysts40
Price Target16.32 (6.74%)
Short Float %N/A
Short Ratio6.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP62.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.08%
Min EPS beat(2)-165.36%
Max EPS beat(2)49.19%
EPS beat(4)1
Avg EPS beat(4)-238.64%
Min EPS beat(4)-782.97%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-182.57%
EPS beat(12)3
Avg EPS beat(12)-86.51%
EPS beat(16)3
Avg EPS beat(16)-163.18%
Revenue beat(2)2
Avg Revenue beat(2)10.23%
Min Revenue beat(2)10.21%
Max Revenue beat(2)10.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.09%
EPS NY rev (1m)0%
EPS NY rev (3m)26.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)94.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.57
P/S 1.38
P/FCF 13.28
P/OCF 11.35
P/B 1.11
P/tB 1.34
EV/EBITDA 8.43
EPS(TTM)-0.34
EYN/A
EPS(NY)1.45
Fwd EY9.46%
FCF(TTM)1.15
FCFY7.53%
OCF(TTM)1.35
OCFY8.81%
SpS11.12
BVpS13.81
TBVpS11.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.05%
ROE 12.56%
ROCE 8.7%
ROIC 6.88%
ROICexc 7.4%
ROICexgc 8.97%
OM 11.68%
PM (TTM) 15.61%
GM 34.3%
FCFM 10.35%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.44
Debt/EBITDA 0.21
Cap/Depr 43.56%
Cap/Sales 1.76%
Interest Coverage 45.24
Cash Conversion 77.05%
Profit Quality 66.35%
Current Ratio 3.94
Quick Ratio 2.28
Altman-Z 4.28
F-Score5
WACC9.15%
ROIC/WACC0.75
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.67%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%775%
EPS Next Y525.4%
EPS Next 2Y158.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)81.84%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%98.42%
Revenue Next Year111.46%
Revenue Next 2Y47.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3447.18%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year-16.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y420.68%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y1109.25%
OCF growth 3Y34.47%
OCF growth 5Y44.76%